Publication:
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma (vol 21, pg 1163, 2015)

Simple item page
dc.contributor.coauthorMazur, P. K.
dc.contributor.coauthorHerner, A.
dc.contributor.coauthorMello, S. S.
dc.contributor.coauthorWirth, M.
dc.contributor.coauthorHausmann, S.
dc.contributor.coauthorSanchez-Rivera, F. J.
dc.contributor.coauthorLofgren, S. M.
dc.contributor.coauthorKuschma, T.
dc.contributor.coauthorHahn, S. A.
dc.contributor.coauthorVangala, D.
dc.contributor.coauthorTrajkovic-Arsic, M.
dc.contributor.coauthorGupta, A.
dc.contributor.coauthorHeid, I.
dc.contributor.coauthorNoel, P. B.
dc.contributor.coauthorBraren, R.
dc.contributor.coauthorKleeff, J.
dc.contributor.coauthorSipos, B.
dc.contributor.coauthorSayles, L. C.
dc.contributor.coauthorHeikenwalder, M.
dc.contributor.coauthorHessmann, E.
dc.contributor.coauthorEllenrieder, V.
dc.contributor.coauthorEsposito, I.
dc.contributor.coauthorJacks, T.
dc.contributor.coauthorBradner, J. E.
dc.contributor.coauthorKhatri, P.
dc.contributor.coauthorSweet-Cordero, E. A.
dc.contributor.coauthorAttardi, L. D.
dc.contributor.coauthorSchmid, R. M.
dc.contributor.coauthorSchneider, G.
dc.contributor.coauthorSage, J.
dc.contributor.coauthorSiveke, J. T.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorErkan, Murat Mert
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2026-08-14T11:20:24Z
dc.date.issued2026
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.ScopusPercentile99
dc.identifier.ScopusQuartileQ1
dc.identifier.WoSPercentile99,7
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1038/s41591-026-04234-8
dc.identifier.eissn1546-170X
dc.identifier.embargoN/A
dc.identifier.endpage764
dc.identifier.issn1078-8956
dc.identifier.issue2
dc.identifier.pubmed41611992
dc.identifier.scopus2-s2.0-105029459643
dc.identifier.startpage763
dc.identifier.urihttp://doi.org/10.1038/s41591-026-04234-8
dc.identifier.urihttps://hdl.handle.net/20.500.14288/34312
dc.identifier.volume32
dc.identifier.wos001674284200001
dc.keywordsPancreatic ductal adenocarcinoma
dc.keywordsHistone
dc.keywordsBET inhibitor
dc.keywordsPancreatic carcinoma
dc.keywordsAdenocarcinoma
dc.languageeng
dc.publisherSpringer
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofNature Medicine
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectExperimental medicine
dc.subjectBiochemistry
dc.subjectGenetics and molecular biology
dc.subjectMolecular biology
dc.titleCombined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma (vol 21, pg 1163, 2015)
dc.typeOther
dspace.entity.typePublication
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext